Decades of research now support the positive relationship of religion/spirituality (R/S) with physical health, mental health, morbidity, and mortality. While lifestyle medicine (LM) practitioners often recognize R/S as important, they can face common challenges of how to integrate R/S into their holistic, patient-centered care. To help, this article presents a faith-practice framework, as a starting point for considering incorporating R/S into LM practice-in light of common concerns and challenges, as a guide for patient-centered care through adjusting lifestyle prescriptions to accommodate individualized R/S beliefs and practices for improved health behavior and outcomes, and as an encouragement to stimulate openness for positive, thoughtful discussion into the future of R/S in LM practice and research.
View Article and Find Full Text PDFCancers (Basel)
October 2024
Starting with its earliest descriptions, melanoma has been recognized as a tumor with a predilection for metastasis to regional lymph nodes. This tendency led to initial recommendations for very aggressive early surgical management of the regional nodal basin. However, those recommendations were the source of much controversy over nearly a century, until the minimally invasive surgical technique of sentinel lymph node (SLN) biopsy was developed by Morton, Cochran and colleagues.
View Article and Find Full Text PDFCancer Treat Res Commun
December 2024
Background: The autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine is produced from dendritic cells (DC) loaded ex vivo with autologous tumor lysate (TL). TLPLDC has been shown to decrease recurrence in resected Stage III/IV melanoma patients in a Phase IIb trial. The TL particle only (TLPO) vaccine is produced by loading of yeast cell wall particles with autologous TL and direct injection allowing for in vivo DC loading.
View Article and Find Full Text PDF